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Introduction
From a public health perspective, the global burden of headache is significant. According to
the World Health Organization (WHO), 46% of adults suffer from headaches (Stovner et al.,
2007; World Health Organization, 2012). The vast majority of headaches are benign, and are
classified as primary headache disorders based on the International Classification of
Headache Disorders-II (ICHD-II) (International Headache Society (IHS), 2005). This class
of headache predominantly includes episodic and chronic forms of tension-type headache
(TTH), migraine headache with and without aura, and cluster headache. In the adult
population, the lifetime prevalence of TTH is 52%, migraine headache 18%, and cluster
headache 1% (Hainer & Matheson, 2013; Jensen & Stovner, 2008). Although TTHs may be
more common, migraine headaches account for the vast majority of disability, and afflict
women at nearly 3 times the rate as they do men – with 17.3% of women and 5.7% of men
meeting the ICHD-II migraine criteria (Buse et al., 2013). Up to 72% of women who present
with headache symptoms meet ICHD-II criteria for episodic, chronic, or probable migraine
(Bigal, Bordini, & Speciali, 2000). Primarily as a result of sex differences in migraine
prevalence and its associated symptom burden, headache is one of the top five disorders
responsible for disability among women worldwide (World Health Organization, 2012).
© 2014 Elsevier Inc. All rights reserved.
Corresponding Author: Shawn M. Kneipp, Ph.D., RN, ANP-BC, APHN-BC Associate Professor The University of North Carolina at
Chapel Hill School of Nursing CB#7460, Carrington Hall Chapel Hill, NC 27599 Office Phone: 919-966-5425
skneipp@email.unc.edu.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
J Nurse Pract. Author manuscript; available in PMC 2015 May 01.
Published in final edited form as:






















Headache-related disability also has a substantial adverse effect on workplace outcomes and
costs. An estimated 31% of adults with migraine report losing at least one day of work in the
prior three months, and are absent an average of 10.7 days per year due to their headache
symptoms (Kessler, Shahly, Stang, & Lane, 2010; Lipton, Stewart, Diamond, Diamond, &
Reed, 2001). Moreover, 51% report their work productivity was reduced by at least 50%
(Lipton et al., 2001). The work absenteeism associated with migraine has been estimated to
result in a loss of productivity of $1,165 per individual, and up to $13 billion dollars
annually in the US (Kessler et al., 2010).
As with many other chronic disease states influenced by stress, behavior, and/or lifestyle
factors, recent studies have found an inverse relationship between socioeconomic status
(SES) and migraine prevalence (Buse et al., 2013; Stewart, Roy, & Lipton, 2013). Using
nationally representative data, Buse and colleagues (2013) found both women and men in
the highest income group were 46% and 55% less likely to have migraine headaches than
those in the lowest income bracket, respectively. Others have found lower income groups
experience more frequent migraine episodes, more severe pain, and more disability from
migraines (Stewart et al., 2013).
In isolation, the higher prevalence among and more severe symptom burden experienced by
women who are socioeconomically disadvantaged (henceforth referred to as
‘disadvantaged’) can be viewed by health care providers as one of many conditions
requiring appropriate diagnosis and treatment in order to improve a patient°s current quality
of life. From a social, economic, and life course perspective, however, the potential impact
of poorly-controlled symptoms over time can be significant. Disadvantaged women, for
example, typically work in employment sectors which do not extend paid sick leave and
may be less tolerant of illness-related absences (Singh-Manoux, Ferrie, Chandola, &
Marmot, 2004; Strully, 2009).
Given the level of disability associated with migraine and the characteristics of their
employment conditions, headache disorders may exacerbate the pre-existing vulnerability of
disadvantaged women to periods of recurrent unemployment and economic instability. As
nurse practitioners providing primary care to this population, we need to better understand
the unique risks that might be incurred by this group that could negatively impact their
economic stability. Despite this, little is known about the impact of headache on
employment among disadvantaged women, in particular. Therefore, the purpose of this
study was to examine the relationships among headache as a chronic health condition
(CHC), health care system and medication utilization patterns for headache, and
employment history among disadvantaged women. More specifically, the aims of the study
were to:
1. Describe (a) the frequency of self-reported headache, (b) health care utilization
patterns related to headache, and (c) patterns of medication use for headache, and
2. Examine the (a) association between self-reported headache as a CHC and recent
health-related job loss, and (b) assess the strength of this association relative to
other high-prevalence chronic health conditions among a sample of SES-
disadvantaged women.
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This study was conducted as a secondary analysis of existing data using a descriptive,
multivariate correlational cross-sectional design. Approval was granted from two university
Institutional Review Boards affiliated with the first author for both data collection and
analysis.
Sample
The study uses baseline data from a recent randomized controlled trial (RCT) that tested a
public health nursing case management intervention with 432 disadvantaged women in
North Central Florida between 2005 and 2010. Details of the intervention development,
RCT methods, and other health and employment-related study findings are reported
elsewhere ([AUTHORS 2009, 2011, 2012). Women in the sample were all unemployed at
baseline and had to either: (a) self-report having at least one health condition considered
‘chronic’ that had been diagnosed by a health provider, or (b) have met depression, general
anxiety disorder, or post-traumatic stress disorder criteria using Structured Clinical
Interview for DSM Disorders (SCID) modules (First, Spitzer, Gibbon, & Williams, 2002).
These criteria were selected given the potential for these conditions to interfere with
physical, social, and/or emotional functioning. “Chronicity” was defined as “conditions that
are generally not cured, once acquired” ([AUTHORS, 2011, p.1760]). Baseline
sociodemographic sample characteristics are presented in Table 1. Women in this sample
were predominantly Black (56.3%), single (88.4%), relatively young (x̄ age = 29.8 years),
and had a lower-level of education (60.2% had a high school diploma/GED or less). All
women enrolled in the study were receiving Medicaid at the time baseline data were
collected.
Measures
Study participants provided self-report data as they completed a comprehensive health-
related questionnaire. The questionnaire included health history-related questions commonly
asked during a primary care visit, investigator-constructed questions, and a battery of
standardized instruments to measure select health outcomes (i.e., the MOS Short-Form 12
Version 2, the Patient Health Questionnaire-9, among others).
The investigator-constructed items asked participants to select the chronic health conditions
(CHCs) they had been diagnosed with by a health care provider from a comprehensive list.
The presence of “headache” as a CHC was identified by women when completing this
checklist, without further specification of headache type. For each CHC selected, they were
asked to provide information on how long they had had the condition (in years), the number
of emergency department (ED) visits made in the past year for the specified condition, and
the medications taken for the specific condition. Headache medication use data were
collected in narrative form and recoded by the study principal investigator into the following
drug class categories: triptans, ergots, beta blockers, anticonvulsants, non-steroidal anti-
inflammatory drugs (NSAIDS), controlled substances, and other over-the-counter
preparations. They were also asked to respond to the following item: “In the past year, how
many jobs have you had to leave due to health?”
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Data analyses were conducted using Stata/SE Version 13.0 (StataCorp LP, 2013).
Descriptive statistics were used to generate means, standard deviations, and frequencies for
the sociodemographic, employment, and health condition characteristics and to meet Aim 1.
To meet Aim 2, we applied chi-square statistics and logistic regression. We used a
hierarchical regression approach to meet Aim 2a, we entered headache as the first
independent variable into the model, followed sequentially by age, race, educational level,
and the number of CHCs as covariates. To meet Aim 2b, a second logistic regression model
was constructed using a forward, stepwise approach with the five most frequently-reported
CHCs as independent variables. To ensure all CHCs even minimally associated with health-
related job loss were represented in the final model, we set the significance criteria at .20 for
model inclusion. We adjusted for age, race, and education level by locking these variables
into the stepwise selection process. We did not, however, adjust for the number of CHCs in
this analysis, as that would have introduced significant multicollinearity within the series of
independent variables of interest incorporated in the model (i.e., the five most frequently-
occurring CHCs). A post-estimation power analysis was conducted for the full Aim 2
regression model (StataCorp LP, 2013). Power was estimated using the probability of job
loss with and without headache along with the intercorrelations among the independent
variables in the full model, which ranged from .001 to .45. Using these parameters, a sample
size of 156 was sufficient to detect the main effects of variables on the full model at a power
of .80. The final analytic sample to meet Aim 1 included all 432 women who completed data
collection at baseline, with the final sample for Aim 2 including the 348 women who had
been employed in the prior year (and hence could be considered “at risk” for job loss).
Results
Headache was the most frequently reported CHC, at 52.6% (n=227). In rank order, the next
four included back pain (49.8%), depression (39.6%), allergies (37.5%), and anxiety
(26.6%). Of the 227 women that reported headache as a CHC, 36.6% (n=83) indicated that
they made at least one ED visit in the prior year due to headache. The vast majority (54.7%,
n=123) with headache were using over-the-counter (OTC) medications (including non-
steroidal anti-inflammatory drugs (NSAIDS), acetaminophen, and aspirin) to treat their
symptoms. Nearly 30% (n=67) were using no medications at all for headache, 7.6% (n=17)
were using triptans, and 8% (n=18) reported taking opiates or scheduled narcotics. Among
women who reported an ED visit for headache in the prior year, 91% reported their
headaches had been present for two or more years. In addition, 83% who were using
controlled substances for headache symptoms, 53% who were taking migraine-specific
medications, and 34% who were taking no medication at all for headache made at least one
visit to the ED in the prior year.
Findings from the Aim 2 logistic regression analyses are presented in Table 2. The
unadjusted odds of having left a job in the prior year due to health (henceforth referred to as
“health-related job loss” for brevity) was nearly twice that for women who reported
headache as a CHC compared to those who did not (OR = 1.99, p<.05). This association
remained essentially unchanged as age, race, and education were sequentially added as
covariates to the model. As noted in Model 5 (Table 2), when the number of CHCs was
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added to the model it became a statistically significant explanatory variable (OR=1.35, p <.
05), while the association between headache and health-related job loss was attenuated and
was no longer statistically significant (OR=1.40). Also noted in Table 2 is the association
between education and health-related job loss, whereby women with a high school diploma
or GED were approximately half as likely to have reported health-related job loss as women
with less than a high school diploma or GED (Models 4 and 5, OR = .51 and .51, p < .05 for
both).
To better understand the association between the number of CHCs, education, and health-
related job loss, and examine how this may differ across women with and without headache,
we conducted additional post-estimation analyses based on the initial regression findings.
First, we simply examined the difference in the mean number of CHCs by job loss using an
independent t-test, where women who had reported a health-related job loss in the prior year
had a slightly higher number of CHCs (x̄ = 4.7) and those that had not reported a health-
related job loss (x̄ = 3.3) (p <.001). We then (separately) included interaction term for (1) the
number of CHCs and headache, and (2) education level and headache to the full regression
model (Model 5, Table 2) while holding other covariates in the model constant (age, race,
and education) (data not shown). The number of CHCs x headache interaction term was not
significant (OR = .98, p = .90), indicating there was no difference in the direction or
magnitude of the relationship between having a higher (or lower) number of CHCs and
health-related job loss based on whether women reported headache. The education level ×
headache interaction was also not statistically significant (OR = .78, p = .39), indicating
there was no difference in the odds of having lost a job due to health in the prior year for
women with headache across levels of education, while holding other covariates in the
model constant.
Finally, to examine what the more nuanced relationship between headache, education, and
number of CHCs on job loss, we also calculated the marginal effect of headache based on
number of CHCs and education level, while adjusting for age and race (Mitchell, 2012).
Given 93% of the sample had between one and seven CHCs, we estimated the marginal
effect of headache for women at each CHC value between one and seven – first while
holding education constant, and then by examining across the three education levels.
Although the marginal effects were not statistically significant, as depicted in Figure 1,
having headache as a CHC increases the probability of health-related job loss from 4.5% for
women with one CHC to just over 8% for those with 6 or 7 CHCs. As depicted in Figure 2,
although the marginal effects were also not statistically significant, there are some trends in
the marginal probabilities of health-related job loss for women with headache that vary not
only by the number of CHCs but also by level of education. Specifically, these marginal
effect trends suggest headache accounts for a 6-8.5% increased probability that women with
less than a 12th grade education had a health-related job loss if they had between 1 to 5
CHCs, while the probability for women with a high school diploma/GED and those with any
type of college education or technical training is slightly less (3.5-7.5%) if they had between
1 and 5 CHCs. These marginal effects increase as the number of CHCs increase across all
groups, until they converge at 6 CHCs, where the probability is essentially the same for
women regardless of education level (8%).
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When the five most frequently occurring CHCs (headache, back pain, depression, allergies,
and anxiety) were directly compared to one another as predictors of health-related job loss,
only headache and allergies were significant (p = .004 and .02, respectively) while adjusting
for age, race, and education. Back pain, depression, and anxiety were not significant
independent predictors of health-related job loss, even though the significance criteria for
inclusion in the model was set liberally (p=.20). This finding indicates that, across the five
most prevalent disorders, headache is one of the CHCs most associated with job loss, as is
having allergies. A headache × allergies interaction term added to the model indicated that
women who reported both headache and allergies as CHCs were nearly three times as likely
to have had a job loss compared to those who had neither headache nor allergies (OR = 2.9,
p = <.001, data not shown).
Study Limitations
There are limitations of this study that should be noted. First, given the way in which CHC
data were collected during the primary study, we are unable to discern which women in the
sample with headache met diagnostic criteria for migraine as opposed to some other form of
headache. In this sample, women identified whether they had headache as a chronic health
condition that had been diagnosed by a provider, but without specificity regarding headache
type. Based on the demographic and health-related composition of the study sample, it is
reasonable to presume the vast majority were suffering from some form of a primary
headache disorder. Given that: (1) at least one study found 72% of women presenting to
primary care clinics with headache met diagnostic criteria for migraine (Bigal et al., 2000),
and (2) the prevalence of migraine among lower-income women is 1.5 times that of women
in higher income groups (20.6% vs. 13.6%, respectively) (Buse et al., 2013), it follows that a
high proportion of women with headache in this study sample would also likely meet ICHD-
II diagnostic criteria for episodic, chronic, or probable migraine (International Headache
Society (IHS), 2005). Although this likelihood is high, the lack of a definitive diagnosis
makes comparing our findings to those of other studies – most of which relate to migraine –
tenuous. Second, while we had a large enough sample to detect the main effects in our
regression models for Aim 2, it is possible that there was not sufficient power to detect the
interactions and more nuanced marginal effect gradients that were explored post-hoc; thus,
the inferences that can be drawn from the trends that were not statistically significant should
be considered only trends, and require further exploration in a larger sample. Despite these
limitations, the findings do make a novel contribution to our understanding of the extent to
which headache is associated with recent health-related job loss among disadvantaged
women.
Discussion & Recommendations
Overall, these findings suggest that low income women who report headache as a CHC are
twice as likely to have lost a job in the prior year due to health regardless of age, race, or
education level. Two other factors played an important role in this relationship: a higher
number of chronic health conditions, and having both headache and allergies as comorbid
conditions. In the context of a greater number of CHCs, headache becomes less relevant in
explaining job loss, while having both headache and allergies increases the likelihood of job
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loss above and beyond having neither of these conditions. In addition, although nuanced,
trends in our data suggest women with headache who also have less than a high school
education or GED may be at a somewhat greater risk for job loss than those with more
education when they have between 1 and 5 CHCs.
These findings are consistent with other findings in the literature. Ku and colleagues (2006),
for example, found the prevalence of migraine was much higher among adults with allergic
rhinitis (34%) than in non-atopic, non-rhinitis controls (2%). Recent study findings further
suggest adults with both a diagnosis of migraine and rhinitis symptoms have greater
headache days per month and headache-related disability than those who do not report
rhinitis of a ‘mixed’ etiology (i.e., with both allergic and non-allergic triggers) (Martin et al.,
2013).
Perhaps most relevant for nurse practitioners and other providers, our findings also suggest
headache symptoms among disadvantaged women may be poorly controlled and/or
managed within the current health care system. Only 56% of adults who meet migraine
criteria are aware their headaches are migraines (Bigal, Borucho, Serrano, & Lipton, 2009),
and only 26% of adults with significant migraine-related functional impairment have
accessed care, received an appropriate diagnosis and/or migraine-specific treatment (Lipton
et al., 2013). Current evidence-based guidelines recommend a stratified treatment approach
for migraine, which urges clinicians to take into account several factors in treatment
decision-making. These include pain intensity, degree of disability, and comorbid
conditions, among others (National Headache Foundation, 2013). While recommended first-
line medications for acute migraine can include simple analgesics such as aspirin,
acetaminophen, and/or NSAIDS, triptans are considered the mainstay of migraine treatment
unless contraindicated. Based on 2009 ambulatory care data, when prescription medications
are given to treat migraine, 82% are for triptans (Smitherman, Burch, Sheikh, & Loder,
2013). Although migraine status was not definitively established in the current sample, the
pattern of medication use in this sample differs somewhat from other published findings of
acute treatment for episodic migraine in the adult population, where OTC preparations were
used by 68%, 32% were using no medications, 19.3% were using migraine-specific
medications, and opiates or butalbital-containing compounds were used by 11.1% and 6%,
respectively (Bigal et al., 2009). Given the higher likelihood that many in our sample would
meet migraine or probable migraine criteria, very few women in our sample were using
triptans (7.6%) compared to triptan use among adults with migraine in the general
population (19.3%) (Bigal et al., 2009).
Compared to the 7.3% of adults with migraine in the ongoing American Migraine
Prevalence and Prevention (AMPP) study cohort who reported an ED visit in the prior year
for headache (Smitherman et al., 2013), the 36.6% of women in our study who visited the
ED for headache in the prior year was remarkably high. This is particularly so when the vast
majority (91%) who made an ED visit also reported their headaches were present for two or
more years. There are several factors that could account for higher ED use in this group.
First, although all women in the study were receiving Medicaid at the time these data were
collected, many probably lacked health insurance at some point in the prior year, which may
have limited primary care access. Second, it is equally likely the result of poor overall
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headache symptom management by the women themselves, their health care providers, or
both. Among women who were taking migraine-specific medications (triptans or ergots) for
headache, more than 50% had an ED visit in the prior year specifically due to their headache
symptoms.
For nurse practitioners who provide care to this population, these findings suggest a need for
more extensive headache symptom evaluation and screening, education on symptom
management, and regular monitoring of treatment efficacy. Given the association of
headache with job loss in this group – particularly in the context of a greater number of
CHCs generally and when allergies are also present – providers should be explicitly asking
women how their headaches may or may not be interfering with functioning at work and
elsewhere. This conversation should include what symptom triggers may be precipitated by
their employment settings or roles, and what their symptom management strategies are when
headaches occur on work days and/or while at work. Given the need for many disadvantaged
women to provide economic support for their families and the characteristics of the jobs
held by this group, ensuring headache symptoms are not contributing to health-related job
loss is imperative.
Finally, further research is needed. While studies have shown lower-income groups have a
higher prevalence of migraine and more functional impairment from migraine, little is
known about how disadvantaged women are managing their headache symptoms, how their
choice of management may be affecting symptoms related to other comorbid conditions, and
how their management strategies may be impacting their functioning in select roles
(particularly with regard to employment). Studies have shown the national impact that
headaches have in terms of lost productivity and wages, and clinical trials have
demonstrated an estimated 31-35% of the productivity loss can be reversed solely with the
use of triptans (Adelman, Sharfman, & Johnson, 1996; Mushet, Miller, Clements, Pait, &
Gutterman, 1996). Generally, however, studies of the symptom management strategies used
by disadvantaged women – and how these might affect role functioning and work
performance – are lacking. Additional research in this area is needed to determine whether
the development of interventions that are more culturally tailored to the daily realities of the
employment conditions and demands of this group.
Conclusions
The presence of headache and a higher number of CHCs increases the probability of health-
related job loss for disadvantaged women. This risk is exacerbated when allergies co-occur,
and may be increased with higher numbers of CHCs and for women with lower levels of
education. The care nurse practitioners provide is often focused on underserved populations,
as well as prevention and symptom management. As such, nurse practitioners are well suited
for not only tailoring pharmacological headache therapy to individual patient characteristics,
but also for providing the additional education, cognitive-behavioral therapies, and/or
symptom monitoring that disadvantaged women may need for optimal headache symptom
management. This is essential to minimize not only headache-related disability, but also to
ensure headaches do not contribute to job loss and further economic instability for this
vulnerable population.
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Table 1
Sociodemographic Characteristics, at Baseline (n=432)
Characteristic % or Mean (SD)
Age 29.8 (8.2)
Race
    Black 56.3%
    White 39.4%
    Other 4.4%
Ethnicity: Hispanic 4.6%
Education level
    < 12th Grade 32.4%
    High school diploma or GED 27.8%
    Some college or technical training 38%
    College degree (≥ associate degree) 1.8%
Total household income (per month, in dollars)
* 656.6 (434.4)
Number of jobs in past year
    0 19.4%
    1-2 61.8%
    3-4 13.7%
    ≥ 5 5.1%
Number of jobs left in past year due to health
    0 70.8%
    ≥ 1 29.2%
Number of chronic health conditions 3.8 (2.3)
*
Includes income per month from food stamps, TANF, work-related income, and income received from others (e.g., family, friends, or partners) on
a regular basis.
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Table 2
Odds of Reporting Leaving Job due to Health within Past Year by Headache as a Reported Chronic Health
Condition (CHC), Adjusted for Select Covariates (n=348)
**
Variables Model 1 Model 2 Model 3 Model 4 Model 5
Independent Variable of Interest
Headache Reported as Chronic Health
Condition
    No Ref. Ref. Ref. Ref. Ref.
    Yes
1.99
*
 (1.25, 3.17) 2.00
*
 (1.26, 3.19) 1.98
*




Select Covariates, Added Sequentially
Age 1.01 (.98, 1.03) 1.01 (.98, 1.04) 1.01 (.98, 1.04) .99 (.95, 1.02)
Race
    White Ref. Ref. Ref.
    Black 1.03 (.64, 1.66) 1.00 (.62, 1.63) 1.39 (.83, 2.35)
    Other 1.49 (.48, 4.64) 1.55 (.49, 4.87) 1.26 (.37, 4.32)
Education
    < 12th grade Ref. Ref.
    High school/GED
.51
*
 (.28, .95) .51
*
 (.27, .95)
    Some college/college degree .79 (.45, 1.36) .66 (.37, 1.19)




        Constant .317 .267 .258 .353 .214
**
Analytic sample includes only women employed in prior year. Odds ratios reported, with 95% confidence intervals in parentheses.
*
Statistically significant at p<.05.
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Table 3
Chronic Health Conditions (CHCs) that Significantly Increase the Odds of Reporting Leaving Job due to
Health within Past Year (n=348)
**
OR SE P (95% CI)
Chronic Health Conditions
        Retained
*
        Headache 2.01 .49 .004 (1.25, 3.23)
        Allergies 1.78 .43 .02 (1.11, 2.86)
        Not Retained
**
        Back pain --- --- --- ---
        Depression --- --- --- ---
        Anxiety --- --- --- ---
*
Adjusted for age, race, and educational level, significance criteria for retention set at p<.20.
**
Three of the five most frequently reported chronic health conditions not retained in the model (p ≥.20)
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